.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Federal Trade Commission
Dow
AstraZeneca
Accenture
Covington
Cerilliant
Julphar
Harvard Business School

Generated: September 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089007

« Back to Dashboard
NDA 089007 describes BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, which is a drug marketed by Sun Pharm Inds, Mallinckrodt Inc, Mayne Pharma Inc, Vintage Pharms, Tedor Pharma Inc, Actavis Labs Ut Inc, Nuvo Pharm Inc, Hikma Pharms, Gilbert Labs, Watson Labs, Graham Dm, Lannett Holdings Inc, Mallinckrodt, Ingenus Pharms Nj, Mikart, Mirror Pharms Llc, Cnty Line Pharms, Nexgen Pharma, and Able, and is included in twenty-eight NDAs. It is available from forty-nine suppliers. Additional details are available on the BUTALBITAL, ACETAMINOPHEN AND CAFFEINE profile page.

The generic ingredient in BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.

Summary for NDA: 089007

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 089007

Suppliers and Packaging for NDA: 089007

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
acetaminophen; butalbital; caffeine
CAPSULE;ORAL 089007 ANDA Marnel Pharmaceuticals, LLC 0682-0804 0682-0804-01 100 CAPSULE in 1 BOTTLE, PLASTIC (0682-0804-01)
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
acetaminophen; butalbital; caffeine
CAPSULE;ORAL 089007 ANDA Mayne Pharma Inc. 51862-179 51862-179-01 100 CAPSULE in 1 BOTTLE, PLASTIC (51862-179-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength325MG;50MG;40MG
Approval Date:Mar 17, 1986TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Harvard Business School
Federal Trade Commission
McKinsey
Mallinckrodt
Julphar
Healthtrust
Fish and Richardson
Cipla
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot